The Two Sigma Advisers LP Increases Position in Envision Healthcare Corp. (EVHC)

Lloyd Doyle
November 15, 2017

Envision Healthcare Corporation (NYSE:EVHC) has a Return on Assets of -2.90%.

By taking a look at the stock's current statistics it can gauged that the stock candle is BULLISH with HIGH volatility. After having $0.68 EPS previously, Envision Healthcare Corporation's analysts see -26.47 % EPS growth.

The company now has an insider ownership of 0.4 Percent and Institutional ownership of 0 Percent. It is 0.00% or $0 reaching $32.57 per share. RBC Capital Markets increased their price target on Envision Healthcare Corp. from $30.00 to $87.00 and gave the stock an "outperform" rating in a report on Thursday, January 5th. LMR Partners LLP purchased a new position in shares of Envision Healthcare Corporation during the second quarter valued at approximately $205,000. The firm earned "Overweight" rating on Thursday, December 15 by Barclays Capital. For shareholders, given the total diluted outstanding shares of 119.48 million, this means overall earnings per share of -3.84. Cutter & CO Brokerage Inc. now owns 3,668 shares of the company's stock valued at $230,000 after purchasing an additional 367 shares in the last quarter.

COPYRIGHT VIOLATION WARNING: This article was first reported by StockNewsTimes and is owned by of StockNewsTimes. If you are viewing this article on another domain, it was copied illegally and reposted in violation of global copyright and trademark law. The original version of this piece can be read at

Several equities analysts have recently weighed in on EVHC shares. On Monday, August 7 the stock rating was maintained by Oppenheimer with "Buy". Mizuho reduced their price objective on Envision Healthcare Corporation from $65.00 to $57.00 and set a "neutral" rating on the stock in a research note on Wednesday, August 9th. The stock of Envision Healthcare Corporation (NYSE:EVHC) has "Buy" rating given on Thursday, July 13 by Cantor Fitzgerald. One analyst has rated the stock with a sell rating, six have issued a hold rating, ten have given a buy rating and one has issued a strong buy rating to the company. The company was maintained on Monday, December 12 by UBS. Zacks Investment Research raised Envision Healthcare Corporation from a "sell" rating to a "hold" rating in a research note on Friday, August 11th. The company has a current ratio of 3.01, a quick ratio of 3.00 and a debt-to-equity ratio of 0.89. Envision Healthcare Corporation has a 1-year low of $23.77 and a 1-year high of $74.75. (EVHC) closed its previous trading session at $24.95 with the loss of -3.03%.

Shares of Envision Healthcare jumped more than 10 percent Tuesday after a news report said some of private equity's biggest names are interested in buying the physician services and surgery center company. That value represents a market adjusting for revenues that have been growing by 142.11 % on a quarterly year/year basis as of the company's last quarterly report.

In case of Revenue Estimates, 11 analysts have provided their consensus Average Revenue Estimates for Envision Healthcare Holdings, 1.7 Billion. Envision Healthcare Corporation (EVHC) average trading volume of 6,704,740 during the past month is 204.35% above its average volume over the past year, indicating that investors have been more active than usual in the stock in recent times. This buyback authorization allows the company to repurchase up to 4.5% of its stock through open market purchases. Currently, Envision Healthcare Holdings, Inc.

Other reports by Iphone Fresh

Discuss This Article